Evidence map›Paper›PMID 22272318›Full record

ArticlePloS one2012

Hydroimidazolone modification of the conserved Arg12 in small heat shock proteins: studies on the structure and chaperone function using mutant mimics.

Ram H Nagaraj, Alok Kumar Panda, Shilpa Shanthakumar, Puttur Santhoshkumar, NagaRekha Pasupuleti, Benlian Wang, Ashis Biswas

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Therapeutic potential of α-crystallin.Biochimica et biophysica acta · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human resistin, a proinflammatory cytokine, shows chaperone-like activity.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ram H NagarajDepartment of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America. ram.nagaraj@case.edu
Alok Kumar Panda
Shilpa Shanthakumar
Puttur Santhoshkumar
NagaRekha Pasupuleti
Benlian Wang
Ashis Biswas
Case Western Reserve University · USIndian Institute of Technology Bhubaneswar · INUniversity of Missouri · US

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
MAILLARD REACTIONS AND OXIDATION IN CATARACTOGENESISR01EY009912 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI NAGARAJ, RAM H · 1998 to 2012
$3.1M
Modifications of Small Heat Shock Proteins in the LensR01EY016219 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI NAGARAJ, RAM H · 2005 to 2009
$1.9M
NEI NIH HHS P30 EY011373NEI NIH HHS P30EY-11373NEI NIH HHS R01 EY009912NEI NIH HHS R01 EY016219NEI NIH HHS R01EY-016219NEI NIH HHS R01EY-09912
6 · The paper itself

Abstract

Methylglyoxal (MGO) is an α-dicarbonyl compound present ubiquitously in the human body. MGO reacts with arginine residues in proteins and forms adducts such as hydroimidazolone and argpyrimidine in vivo. Previously, we showed that MGO-mediated modification of αA-crystallin increased its chaperone function. We identified MGO-modified arginine residues in αA-crystallin and found that replacing such arginine residues with alanine residues mimicked the effects of MGO on the chaperone function. Arginine 12 (R12) is a conserved amino acid residue in Hsp27 as well as αA- and αB-crystallin. When treated with MGO at or near physiological concentrations (2-10 µM), R12 was modified to hydroimidazolone in all three small heat shock proteins. In this study, we determined the effect of arginine substitution with alanine at position 12 (R12A to mimic MGO modification) on the structure and chaperone function of these proteins. Among the three proteins, the R12A mutation improved the chaperone function of only αA-crystallin. This enhancement in the chaperone function was accompanied by subtle changes in the tertiary structure, which increased the thermodynamic stability of αA-crystallin. This mutation induced the exposure of additional client protein binding sites on αA-crystallin. Altogether, our data suggest that MGO-modification of the conserved R12 in αA-crystallin to hydroimidazolone may play an important role in reducing protein aggregation in the lens during aging and cataract formation.

Indexed as

alpha-Crystallin A Chainalpha-Crystallin B ChainAmino Acid SequenceArginineBinding SitesCircular DichroismElectrophoresis, Polyacrylamide GelHSP27 Heat-Shock ProteinsImidazolesKineticsMolecular ChaperonesMolecular Sequence DataMolecular StructureMutationProtein BindingProtein Structure, Secondaryalpha-Crystallin A Chainalpha-Crystallin B ChainArginineHSP27 Heat-Shock ProteinsImidazolesimidazoloneMolecular ChaperonesPyruvaldehydeRecombinant Proteins

Identifiers

PMID22272318
PMCPMC3260246
OpenAlexW2084771583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.